WebDisclosure WebDisclosure
Basculer en Français
10965 Companies
240124 Keywords
168894 Articles
129222 Press releases
Headlines Articles Press releases DSE Healthcare Solutions Remove
  1. Home
  2. Companies
  3. DSE Healthcare Solutions
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/15/2024 at 19:30, 2 years 5 months ago

    Acnomel: A Dermatologist-Recommended Acne Solution Devoid of Cancer-Causing Agents

    Acnomel Skincare Acne Treatment Sulfur Safe Skincare Alternatives
  • BRIEF

    published on 03/15/2024 at 19:30, 2 years 5 months ago

    Acnomel : une solution contre l'acné recommandée par les dermatologues et dépourvue d'agents cancérigènes

    Acnomel Soins De La Peau Traitement De L'acnée Soufre Alternatives Sûres Aux Soins De La Peau
  • PRESS RELEASE

    published on 03/15/2024 at 19:25, 2 years 5 months ago

    Dermatologist Recommended Acnomel Offers Safe Alternative To Treat Acne

    Consumers seek safer acne treatments amid concerns over cancer-causing benzene in popular products. Acnomel tinted acne cream gains attention with proven efficacy and unique formulation
    Acnomel Acne Treatments Cancer-causing Benzene Safe Skincare Products DSE Healthcare Solutions
    Logo of DSE Healthcare Solutions
Accesswire
  • Published on 09/11/2026 at 17:00, 3 hours 58 minutes ago

    Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

  • Published on 09/11/2026 at 17:00, 3 hours 58 minutes ago

    Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan

  • Published on 09/11/2026 at 15:25, 5 hours 33 minutes ago

    Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity

  • Published on 09/11/2026 at 15:00, 5 hours 58 minutes ago

    Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

  • Published on 09/11/2026 at 14:30, 6 hours 28 minutes ago

    AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value

View all ACCESSWIRE
EQS Group
  • Published on 09/11/2026 at 19:44, 1 hour 13 minutes ago

    DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031

  • Published on 09/11/2026 at 18:15, 2 hours 42 minutes ago

    CGTN: How BRICS creates new opportunities for Global South development

  • Published on 09/11/2026 at 18:07, 2 hours 51 minutes ago

    Holding(s) in Company

  • Published on 09/11/2026 at 18:06, 2 hours 51 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 09/11/2026 at 18:00, 2 hours 58 minutes ago

    ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all EQS
Les Echos
  • Published on 09/11/2026 at 07:00, 13 hours 58 minutes ago

    Transparantiekennisgeving van Baltisse Groep

  • Published on 09/11/2026 at 07:00, 13 hours 58 minutes ago

    Transparency notification by Baltisse Group

  • Published on 09/11/2026 at 07:00, 13 hours 58 minutes ago

    BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

  • Published on 09/11/2026 at 07:00, 13 hours 58 minutes ago

    BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ

  • Published on 09/10/2026 at 19:30, 1 day 1 hour ago

    Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy